16,833,726 Common Stock of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2021. These Common Stock will be under lockup for 181 days starting from 10-DEC-2020 to 9-JUN-2021.

Details:
The executive officers and directors have agreed that they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any shares of common stock or securities convertible into or exchangeable or exercisable for any shares of common stock, for a period of 180 days after the date of the final prospectus supplement without the prior written consent of Goldman Sachs & Co. LLC, BofA Securities, Inc. and Evercore Group L.L.C.